Health-related Quality of Life and Depression after Radical Prostatectomy or Hormonal Therapy.
10.5388/aon.2013.13.4.248
- Author:
Geum Ja YANG
1
;
Jeong Hee KANG
;
In Sun SUH
;
Hye Young KIM
Author Information
1. Department of Nursing, Chonbuk National University Hospital, Jeonju, Korea.
- Publication Type:Original Article
- Keywords:
Prostatic Neoplasms;
Quality of Life;
Depression;
Prostatectomy;
Hormone Replacement Therapy
- MeSH:
Depression*;
Hormone Replacement Therapy;
Humans;
Prostatectomy*;
Prostatic Neoplasms;
Quality of Life*
- From:Asian Oncology Nursing
2013;13(4):248-255
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The aim of this study was to compare the health-related quality of life (HQOL) and depression in prostate cancer patients with radial prostatectomy or hormonal therapy more than 6 months ago. METHODS: A total of 116 patients participated in the study (83 radical prostatectomy patients and 33 hormonal therapy). Data were collected from 13th September to 13th November 2012, using two instruments-translated into Korean: Expanded Prostate Cancer Index Composite and Geriatric Depression Scale Short Form. RESULTS: Hormonal therapy participants reported significantly higher scores of HQOL than radical prostatectomy participants did (p=.002). The HQOL subscales with significant differences were urinary function (p<.001) and incontinence (p<.001) under urinary domain and sexual bother (p<.001) under sexual domain. The level of depression was not significantly different between the two treatment groups. There were moderate negative correlations between HQOL and depression in both groups. CONCLUSION: Many of prostate cancer patients reported treatment-related functional deteriorations in urinary and sexual domains and they were depressed even more than 6 months after the treatment completion. To manage prostate cancer patients' HQOL and depression, clinicians including nurses should evaluate patients' complaints according to their treatment modality and intervene accordingly.
